MedElevator
Войти в исследования Journal of psychosomatic research · 2026
Psychosomatic and cognitive outcomes of non-SARS-Cov-2 recent respiratory infections among Chinese adults: A nationwide investigation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Lei, Yuan Yucheng, Jiang Wenhao, Jiang Chenguang, Duan Huijun, Yu Bin, Zou Tao, Li Zhongyan, Xiong Peng, Yue Yingying, Sun Taipeng, Zhang Yuqun, Xu Wei, Zhang Yubo, Xin Xiaoyun, Hou Zhenhua, Hu Changchun, Chen Jue, Wang Juncai, Xu Zhi, Yuan Yonggui
Аннотация
OBJECTIVES: While post-COVID symptoms are well-documented, symptoms following non-SARS-CoV-2 recent respiratory tract infections (RRIs) remain understudied. This study aimed to investigate the prevalence, associated factors of symptoms following RRIs.
METHODS: A nationwide cross-sectional survey of 61,012 adults was conducted between December 2023 and January 2024. Self-reported RRIs within one month, SARS-CoV-2 infections, infection times and severity of COVID-19 were documented. Psychosomatic symptoms, subjective cognitive and well-being were measured using brief psychosomatic symptom scale (BPSS), brief brain fog scale (BBFS) and 5-item World Health Organization well-being index (WHO-5). Logistic and linear regressions and pathway analyses were used to examine associated factors.
RESULTS: Among 15,715 participants reporting RRIs, 40.8% exhibited psychosomatic symptoms (vs. 25.6% in non-RRI group, FDR-adjusted P < 0.05) and 17.5% reported cognitive symptoms (vs. 9.0%, FDR-adjusted P < 0.05). The most prevalent symptoms included sleep difficulty (18.2%), depression (16.7%), and pain (15.2%). RRIs was more strongly associated with most symptoms than SARS-CoV-2 (OR: 1.41-2.02 vs. 0.88-1.37). Socioeconomic status (OR < 1, FDR-adjusted P < 0.05) and comorbidities (OR > 1, FDR-adjusted P < 0.05) were associated with these symptoms. Participants with both RRIs and previous SARS-CoV-2 infections exhibited increased symptom burdens (psychosomatic: 41.6%; cognitive: 18.0%). Psychosomatic and cognitive symptoms accounted for 71.7% (95% CI: 68.2%-75.4%) and 56.3% (95% CI: 53.1%-59.7%) effects of RRIs on well-being.
CONCLUSION: RRIs were associated with higher symptom reporting than COVID-19 exacerbated by socioeconomic disparities and comorbidities. Our preliminary findings call for integrated frameworks in practice that managing psychosomatic and cognitive symptoms and socioeconomic factors.
METHODS: A nationwide cross-sectional survey of 61,012 adults was conducted between December 2023 and January 2024. Self-reported RRIs within one month, SARS-CoV-2 infections, infection times and severity of COVID-19 were documented. Psychosomatic symptoms, subjective cognitive and well-being were measured using brief psychosomatic symptom scale (BPSS), brief brain fog scale (BBFS) and 5-item World Health Organization well-being index (WHO-5). Logistic and linear regressions and pathway analyses were used to examine associated factors.
RESULTS: Among 15,715 participants reporting RRIs, 40.8% exhibited psychosomatic symptoms (vs. 25.6% in non-RRI group, FDR-adjusted P < 0.05) and 17.5% reported cognitive symptoms (vs. 9.0%, FDR-adjusted P < 0.05). The most prevalent symptoms included sleep difficulty (18.2%), depression (16.7%), and pain (15.2%). RRIs was more strongly associated with most symptoms than SARS-CoV-2 (OR: 1.41-2.02 vs. 0.88-1.37). Socioeconomic status (OR < 1, FDR-adjusted P < 0.05) and comorbidities (OR > 1, FDR-adjusted P < 0.05) were associated with these symptoms. Participants with both RRIs and previous SARS-CoV-2 infections exhibited increased symptom burdens (psychosomatic: 41.6%; cognitive: 18.0%). Psychosomatic and cognitive symptoms accounted for 71.7% (95% CI: 68.2%-75.4%) and 56.3% (95% CI: 53.1%-59.7%) effects of RRIs on well-being.
CONCLUSION: RRIs were associated with higher symptom reporting than COVID-19 exacerbated by socioeconomic disparities and comorbidities. Our preliminary findings call for integrated frameworks in practice that managing psychosomatic and cognitive symptoms and socioeconomic factors.